在四十岁时使用传统的试管婴儿
Mete Işıkoğlu1, Ayşenur Avcı1, Ayşe Kendirci Çeviren1
1Gelecek IVF, Antalya, Türkiye.
Journal of the Turkish German Gynecological Association
|January 12, 2026
概括
传统的体外受精 (C-IVF) 对40岁以上的女性显示出令人满意的结果. 这种方法比细胞内质精子注射 (ICSI) 建议使用,因为其成本较低,并且在晚年孕产妇患者中具有可比的结果.
科学领域:
- 生殖医学 生殖医学
- 不孕症治疗 不孕症治疗
- 母亲的年龄 母亲的年龄
背景情况:
- 内细胞质内注射 (ICSI) 越来越多地使用,通常与国际指导方针相反.
- 晚年母亲的年龄在生育治疗中越来越令人担忧.
研究的目的:
- 评估40岁及以上妇女常规体外受精 (C-IVF) 的有效性.
- 为了比较C-IVF与ICSI用于治疗晚期母亲年龄患者的不孕症.
主要方法:
- 对40岁及以上女性非男性因子不孕症病例的分析.
- 主要结果指标包括受精,植入,活产和流产率.
主要成果:
- 一组204名患者 (平均年龄42.3) 的受精率为74.69%.
- 活产率为12.25%,平均1.77个胚胎被移植.
- 植入和临床怀孕率分别为10.44%和18.62%.
结论:
- 传统的体外受精 (C-IVF) 证明了40岁及以上妇女的受精,植入和活产率令人满意.
- 对于这一群体来说,C-IVF是ICSI的成本效益和更简单的替代方案.
- 应将C-IVF视为晚年孕产妇妇女的首选方法.
相关概念视频
In Vitro Fertilization
870
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
870
Infertility in Females
3.6K
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
3.6K
Infertility in Males
522
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
522
Meiosis II
206.6K
Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each...
206.6K
Oogenesis
68.9K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
68.9K


